Longevity Acquisition Corp (Nasdaq: LOAC) is a blank check company that completed its initial public offering in 2019 with a strategic focus on business combination targets in the healthcare and longevity sector. The company filed its Form 10-K with the Securities and Exchange Commission on April 30, 2020, bearing accession number 0001104659-20-054472, reflecting its status as an active special purpose acquisition company in the target-search phase. Structured as a Cayman Islands entity, LOAC was formed to pursue acquisitions within health sciences, biotechnology, and longevity-focused industries. The annual filing captures the company's financial position and operational disclosures for its first year as a public vehicle. Sign up at SpacDesk for full filing histories, sponsor profiles, and real-time deal tracking on LOAC and the broader SPAC market.